The FDA announced that a new type 1 diabetes stem cell therapy from Vertex has been cleared to enter clinical trials in the United States. The therapy, which hopes to...

New study results showed that using an artificial pancreas, or fully closed-loop automated insulin delivery system, improved time spent in a healthy glucose range by...

Adults with newly diagnosed type 2 diabetes are at higher risk of having undetected pancreatic cancer. A U.S. clinical trial is recruiting this population to evaluate a...

A clinical trial is recruiting adults with type 1 or type 2 diabetes to investigate a potential oral medication for diabetic retinopathy and other eye complications of...

A U.S. clinical trial is recruiting adolescents between the ages of 12 and 18 with type 1 diabetes who are willing to add an SGLT2 inhibitor to their treatment regimen...

A U.S. clinical trial is recruiting adolescents and adults between the ages of 14 and 45 with recently diagnosed type 1 diabetes to evaluate the effectiveness of...

A U.S. clinical trial is recruiting children between the ages of 4 and 17 with type 1 or type 2 diabetes whose families are interested in having their children try...

A once-weekly insulin option would bring several benefits to people with type 1 diabetes. This study will evaluate the safety and glucose-lowering effect of an...

Metformin is the world’s most common diabetes medication and is often referred to as a miracle drug. However, use of metformin in those with chronic kidney disease (CKD...

Clinical researchers are working to discover newer strategies and medications to help children with diabetes live healthier, happier lives. Here are some exciting...

A Bayer clinical trial is seeking to evaluate the safety and efficacy of finerenone, which treats chronic kidney disease, alongside empagliflozin, a type 2 diabetes drug...

An actively recruiting clinical trial is seeking to evaluate a new drug to treat diabetic kidney disease (DKD). This new injectable drug will be given alongside Farxiga...

Encouraging trial results from Novo Nordisk show that a new combination therapy in development could help people lower their A1C and weight dramatically. With the...

Approximately 17% of people with diabetes have diabetic cardiomyopathy, a dangerous complication that can lead to heart failure. This clinical trial is focused on...

A fully virtual six-month clinical trial is recruiting 300 people with type 1 and type 2 diabetes who are interested in trying continuous glucose monitoring (CGM) with...

The Your SAY: Hypoglycemia study is a 30-minute online survey that will help an international research team understand how severe low blood sugar affects quality of life...

In the search for new and innovative ways to treat type 1 diabetes, researchers have looked to develop therapies that protect or improve the body’s ability to produce...

Vertex Pharmaceuticals announced its intention to acquire the biotechnology company ViaCyte for $320 million in cash, merging two leaders in beta cell replacement...

Researchers are dedicated to developing new mealtime insulins that can help improve glucose management and prevent highs and lows. Exciting new concentrated, ultra-rapid...

See if you are eligible to participate in this study looking at whether the One Touch Solutions platform and its associated partner programs can help people better...